On the role of fluoro-substituted nucleosides in DNA radiosensitization for tumor radiation therapy
On the role of fluoro-substituted nucleosides in DNA radiosensitization for tumor radiation therapy
Kopyra, J.; Keller, A.; Bald, I.
Abstract
Gemcitabine (2’,2’-difluorocytidine) is a well-known radiosensitizer routinely applied in concomitant chemoradiotherapy. During irradiation of biological media with high-energy radiation secondary low-energy (< 10 eV) electrons are produced that can directly induce chemical bond breakages in DNA by dissociative electron attachment (DEA). Here, we investigate and compare DEA to the three molecules 2’-deoxycytidine, 2’-deoxy-5-fluorocytidine, and gemcitabine. Fluorination at specific molecular sites, i.e., nucleobase or sugar moiety, is found to control electron attachment and subsequent dissociation pathways. The presence of two fluorine atoms at the sugar ring results in more efficient electron attachment to the sugar moiety and subsequent bond cleavages. For the formation of the dehydrogenated nucleobase anion, we obtain an enhancement factor of 2.8 upon fluorination of the sugar, whereas the enhancement factor is 5.5 when the nucleobase is fluorinated. The observed fragmentation reactions suggest enhanced DNA strand breakage induced by secondary electrons when gemcitabine is incorporated into DNA.
Beteiligte Forschungsanlagen
- Ionenstrahlzentrum DOI: 10.17815/jlsrf-3-159
Verknüpfte Publikationen
- DOI: 10.17815/jlsrf-3-159 is cited by this (Id 19522) publication
-
RSC Advances 4(2014), 6825-6829
DOI: 10.1039/c3ra46735j
Cited 33 times in Scopus
Permalink: https://www.hzdr.de/publications/Publ-19522